NDC product
UPNEEQ
NDC 73687-062 · RVL Pharmaceuticals, Inc.
Key facts
| Product NDC | 73687-062 |
|---|---|
| Proprietary name | UPNEEQ |
| Nonproprietary name | Oxymetazoline hydrochloride ophthalmic |
| Substances | OXYMETAZOLINE HYDROCHLORIDE |
| Dosage form | SOLUTION/ DROPS |
| Route | OPHTHALMIC |
| Labeler | RVL Pharmaceuticals, Inc. |
| Product type | HUMAN PRESCRIPTION DRUG |
| Marketing category | NDA |
| Application number | NDA212520 |
| Pharmacologic classes | Imidazolines [CS], Increased Sympathetic Activity [PE], Vasoconstriction [PE], Vasoconstrictor [EPC] |
| Marketing start | Aug 21, 2020 |
| Listing certified through | Dec 31, 2027 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: